ANNX - Annexon Inc
IEX Last Trade
5.69
-0.240 -4.218%
Share volume: 614,339
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.93
-0.24
-4.05%
Fundamental analysis
27%
Profitability
25%
Dept financing
20%
Liquidity
50%
Performance
25%
Performance
5 Days
-3.23%
1 Month
-8.21%
3 Months
20.51%
6 Months
3.83%
1 Year
103.57%
2 Year
5.75%
Key data
Stock price
$5.69
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.57 - $8.40
52 WEEK CHANGE
$0.96
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
Company detail
CEO:
Region: US
Website: annexonbio.com
Employees: 86
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: annexonbio.com
Employees: 86
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration (cmnd).
Recent news